We found 1998 results for your search.
I am a clinician investigator at Beth Israel Deaconess Medical Center and an Assistant Professor at Harvard Medical School. I see patients through my primary care clinic part-time, while the bulk of my work involves executing clinical trials focused on disease prevention. I spent over 10 years in training at Johns Hopkins University, completing my… Continue reading Stephen Juraschek, MD
I am an Associate Professor of Neurology at Harvard Medical School and a practicing stroke neurologist at Beth Israel Deaconess Medical Center. A primary focus of my efforts has been to develop coherent management strategies for stroke care that encompasses different phases of stroke recovery. Whereas significant advances have been made in management of acute… Continue reading Sandeep Kumar
The more than 2.1 million people living in nursing homes and residential care communities in the United States have emerged as a group hit particularly hard by the pandemic. There have been approximately 101,000 COVID-19 deaths in these long-term care facilities, accounting for about 39% of virus-related deaths nationwide.
Since the onset of COVID-19, Ariadne Labs began exploring ways to address this crisis in nursing homes. Our initial research quickly uncovered deeper structural problems in long term care facilities, exacerbated by the effects of the pandemic. Urgent change is required to transform nursing homes into sites of clinical excellence, where we can offer the best of healthcare in a home-like setting. Ariadne Labs has committed to support a year of design work to develop a new model of care in nursing homes, including a suite of tools that supports structural changes in care delivery with expected positive outcomes for both staff and residents. Our model is built on a framework of integrating the best of healthcare with the best of home in these long term care facilities.
When COVID-19 vaccines become available in the US, states will need to allocate them to their highest priority populations. The Vaccine Allocation Planner for COVID-19 helps state and county decision prepare for different scenarios.
By Asaf Bitton, MD, MPH; Evan Benjamin, MD, MS, FACP; Margaret Ben-Or, MPH Many K–12 schools in the United States are closing in on the end of their first term of the 2020–2021 school year, a year unlike anything we have experienced in recent history due to the COVID-19 pandemic. Some schools have opened their… Continue reading Good News: In The Debate About School Re-opening, There Are A Few Things Schools Don’t Actually Need To Do
Data-driven tool will help state and county decisionmakers operationalize phased vaccine distribution.